Back to Stakeholders

Global full-service biotech-focused CRO supporting development across clinical phases, with publicly stated psychedelic trial collaborations and formal partnerships with experienced psychedelics research centers.

Clinical Trial Infrastructure Snapshot

CROs & Full-Service Trial Delivery

Service Model

Full-Service CRO

Coverage

Global

Psychedelic Experience

Verified Psychedelic Trial Experience

Last Verified

Apr 8, 2026

Lifecycle Coverage

Feasibility & Protocol DesignStudy Startup & Site ActivationRecruitment & RetentionTrial Operations & MonitoringData Management & BiostatisticsSafety Operations / PharmacovigilanceCloseout & Reporting

Phase Coverage

Phase IPhase IIPhase IIIPhase IV / Post-Marketing

Capabilities

Site Network AccessBiometrics / StatisticsSafety / Pharmacovigilance

Verification

Verified

Experience Notes

Novotech announced an MOU with NZCR specifically in the psychedelics context and reports prior collaboration on multiple psychedelic studies.

Primary Service Link

Service Notes

Biotech-specialist CRO model with multi-region execution capabilities and recurring clinical-site partnership structure for early and later phase programs.

Quick Facts

Website
Visit